Acute cognitive effects of donepezil in young, healthy volunteers

Human Psychopharmacology

Volumn 24, Issue 6, 2009, Pages 453-464

  Zaninotto, Ana L C ^a   Bueno, Orlando F A ^a   Pradella Hallinan, Márcia ^a   Tufik, Sérgio ^a   Rusted, Jenny ^b   Stough, Con ^c   Pompéia, Sabine ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

^c SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Acetylcholinesterase inhibitor; Cognition; Donepezil; Memory; Performance; Working memory

Indexed keywords

ACETYLCHOLINE; DONEPEZIL; PLACEBO;

ACUTE DRUG ADMINISTRATION; ADULT; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL TASK; MENTAL TEST; MOOD CHANGE; NORMAL HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECALL; SPATIAL MEMORY; TIME TO MAXIMUM PLASMA CONCENTRATION; VISUAL MEMORY; WORD RECOGNITION;

ADULT; AFFECT; CHOLINESTERASE INHIBITORS; COGNITION; DOUBLE-BLIND METHOD; HUMANS; INDANS; MALE; MEMORY; NOOTROPIC AGENTS; PIPERIDINES; TIME FACTORS; YOUNG ADULT;

EID: 70349549899     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1044     Document Type: Article

References (70)

1. Allen RJ, Baddeley AD, Hitch GJ. 2006. Is the binding of visual features in working memory resource-demanding? J Exp Psychol Gen 135: 298-313.
2. Baddeley A, Cocchini G, Della Sala S, Logie RH, Spinnler H. 1999. Working memory and vigilance: evidence from normal aging and Alzheimer's disease. Brain Cogn 41: 87-108.
3. Baddeley A. 2000. The episodic buffer: a new component of working memory? Trends Cogn Sci 4: 417-423.
4. Baddeley A,Wilson B. 2002. Prose recall and amnesia: implications for the structure of working memory. Neuropsychologia 40: 1737-1743.
5. Baddeley A. 2007. Working Memory, Thought, and Action (Oxford Psychology Series), Vol. 1. Oxford University Press: Oxford.
6. Beglinger LJ, Gaydos BL, Kareken DA, Tangphao-Daniels O, Siemers ER, Mohs RC. 2004. Neuropsychological test performance in healthy volunteers before and after donepezil administration. J Psychopharmacol 18: 102-108.
7. Beglinger LJ, Tangphao-Daniels O, Kareken DA, Zhang L, Mohs R, Siemers ER. 2005. Neuropsychological test performance in healthy elderly volunteers before and after donepezil administration: a randomized, controlled study. J Clin Psychopharmacol 25: 159-165.
8. Bond AJ, Lader MH. 1974. The use of analogue scales in rating subjective feelings. Br J Psychol 47: 211-218.
9. Burt T. 2000. Donepezil and related cholinesterase inhibitors as mood and behavioral controlling agents. Curr Psychiatry Rep 2: 473-478.
10. Broocks A, Little JT, Martin A, et al. 1998. The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls. Biol Psychiatry 43: 408-416.
11. Cacabelos R, Llovo R, Fraile C, Fernández-Novoa L. 2007. Pharmacogenetic aspects of therapy with cholinesterase inhibitors: the role of CYP2D6 in Alzheimer's disease pharmacogenetics. Curr Alzheimer Res 4: 479-500.
12. Correa DD, Gorenstein C. 1988a. Bateria de testes de memória. Parte 1: critérios de elaboração e avaliação. Arq Bras Psicol 38: 24-35.
13. Correa DD, Gorenstein C. 1988b. Bateria de testes de memória. Parte 2: critérios de elaboração e avaliação. Arq Bras Psicol 40: 42-53.
14. Cummings JL, McRae T, Zhang R. 2006. Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders. Am J Geriatr Psychiatry 14: 605-612.
15. Curran HV, Pooviboonsuk P, Dalton JA, Lader MH. 1998. Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine. Psychopharmacology 135: 27-36.
16. Curran VH. 2000. Psychopharmacological perspectives on memory. In The handbook of memory, Tulving E, Craik FIM (eds). Oxford University Press: Oxford; 539-556.
17. Devi G, Massimi S, Schultz S, Khosrowshahi L, Laakso UK. 2007. A double-blind, placebo-controlled trial of donepezil for the treatment of menopause-related cognitive loss. Gend Med 4: 352-358.
18. Dreisbach G. 2006.Howpositive affectmodulates cognitive control: the costs and benefits of reduced maintenance capability. Brain Cogn 60: 11-19.
19. Dooley M, Lamb HM. 2000. Donepezil: a review. Drugs Aging 16: 199-226.
20. Ellis JR, Ellis KA, Bartholomeusz CF, et al. 2006. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans. Int J Neuropsychopharmacol 8: 1-15.
21. FitzGerald DB, Crucian GP, Mielke JB, et al. 2008. Effects of donepezil on verbal memory after semantic processing in healthy older adults. Cogn Behav Neurol 21: 57-64.
22. Furey ML, Pietrini P, Alexander GE, et al. 2000a. Time course of pharmacodynamic and pharmacokinetic effects of physostigmine assessed by functional brain imaging in humans. Pharmacol Biochem Behav 66: 475-481.
23. Furey ML, Pietrini P, Haxby JV. 2000b. Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science 290: 2315-2319.
24. Furey ML, Ricciardi E, Schapiro MB, Rapoport SI, Pietrini P. 2008a. Cholinergic enhancement eliminates modulation of neural activity by task difficulty in prefrontal cortex during working memory. J Cogn Neurosci 20: 1-12.
25. Furey ML, Pietrini P, Haxby JV, Drevets WC. 2008b. Selective effects of cholinergic modulation on task performance during selective attention. Neuropsychopharmacology 33: 913-923.
26. Garaas TW, Pomplun M. 2008. Inspection time and visual-perceptual processing. Vision Res 48: 523-537.
27. Gorenstein C, Andrade L. 1996. Validation of a Portuguese version of the Beck Depression Inventory and State-Trait Anxiety Inventory in Brazilian Subjects. Braz J Med Biol Res 29: 453-457.
28. Green A, Ellis KA, Ellis J, et al. 2005. Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans. Pharmacol Biochem Behav 81: 575-584.
29. Grön G, Kirstein, Thielscher A, Riepe MW, Spitzer M. 2005. Cholinergic enhancement of episodic memory in healthy young adults. Psychopharmacology 182: 170-179.
30. Grön G, Brandenburg I, Wunderlich AP, Riepe MW. 2006. Inhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypotesis. Neurobiol Aging 27: 78-87.
31. Guimarães FS. 1998. Escalas analógicas visuais na avaliação de estados subjetivos. Psiq Clin 25: 217-222.
32. Hasselmo ME, Stern CE. 2006. Mechanisms underlying working memory for novel information. Trends Cogn Sci 10: 487-493.
33. Hutchison CW, Nathan PJ, Mrazek L, Stough C. 2001. Cholinergic modulation of speed of early information processing: the effect of donepezil on inspection time. Psychopharmacology 155: 440-442.
34. Jann MW, Shirley KL, Small GW. 2002. Clinical pharmacokinetics and pharmacodinamics of cholinesterase inhibitors. Clin Pharmacokinet 41: 719-739.
35. Johnson DK, Storandt M, Morris JC, Langford ZD, Galvin JE. 2008. Cognitive profiles in dementia: Alzheimer disease vs. healthy brain aging. Neurology 71: 1783-1789.
36. Kessels RP, Postma A, de Haan EH. 1999. Object location: a program for setting up, running, and analyzing experiments on memory for object locations. Behav Res Methods Instrum Comput 31: 423-428.
37. Kessels RP, van den Berg E, Ruis C, Brands AM. 2008. The backward span of the Corsi block-tapping task and its association with theWAIS-III digit span. Assessment 15: 426-434.
38. Khateb A, Ammann J, Annoni JM, Diserens K. 2005. Cognition-enhancing effects of donepezil in traumatic brain injury. Eur Neurol 54: 39-45.
39. Koontz JMA, Baskys AMD. 2005. Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study. Am J Alzheimers Dis Dem 20: 295-302.
40. Meinke A, Thiel CM, Fink GR. 2006. Effects of nicotine on visuo-spatial selective attention as indexed by event-related potentials. Neuroscience 141: 201-212.
41. Miyake A, Friedman NP, Rettinger DA, Shah P, Hegarty M. 2001. How are visuospatial working memory, executive functioning, and spatial abilities related? A latent-variable analysis. J Exp Psychol Gen 130: 621-640.
42. Miyake A, Friedman NP, Emerson MJ,Witzki AH, Howerter A, Wager TD. 2000. The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: a latent variable analysis. Cogn Psychol 41: 49-100.
43. Nathan PJ, Baker A, Carr E, et al. 2001. Cholinergic modulation of cognitive function in healthy subjects: acute effects of donepezil, a cholinesterase inhibitor. Hum Psychopharmacol 16: 481-483.
44. Nathan PJ, Stough C. 2001. Inspection time: a neuropsychophysiological test for measuring the functional integrity of the cholinergic system. Med Hypotheses 57: 759-760.
45. Pickering SJ. 2001. Cognitive approaches to the fractionation of visuospatial working memory. Cortex 37: 457-473.
46. Pickering SJ, Gathercole SE, Hall M, Lloyd SA. 2001. Development of memory for pattern and path: further evidence for the fractionation of visual and spatial short-term memory. Quart J Exp Psychol 54: 397-420.
47. Poirier J. 2002. Evidence that the clinical effects of cholinesterase inhibitors are related to potency and targeting of action. Int J Clin Pract Suppl 127: 6-19.
48. Pompéia S, Pradella-Hallinan M, Manzano GM, Bueno OFA. 2008. Effects of lorazepam on visual perceptual abilities. Hum Psychopharmacol 23: 183-192.
49. Postma A, Izendoorn R, Haan EHF. 1998. Sex differences in object location memory. Brain Cogn 36: 334-345.
50. Postma A, Jager G, Kessels RP, Koppeschaar HP, van Honk J. 2004. Sex differences for selective forms of spatial memory. Brain Cogn 54: 24-34.
51. Postma A, Kessels RPC, van Asselen M. 2008. How the brain remembers and forgets where things are: the neurocognition of object-location memory. Neurosci Biobehav Rev 32: 1339-1345.
52. Repovs G, Baddeley A. 2006. The multi-component model of working memory: explorations in experimental cognitive psychology. Neuroscience 139: 5-21.
53. Risch SC, Horner MD, McGurk SR, et al. 2006. Donepezil effects on mood in patients with schizophrenia and schizoaffective disorder. Int J Neuropsychopharmacol 9: 603-605.
54. Rogers SL, Cooper NM, Sukovaty R, Pederson JE, Lee JN, Friedhoff LT. 1998. Pharmacokinetic and pharmacodinamic profile of donepezil HCl following multiple oral doses. Br J Clin Pharmacol 46: 7-12.
55. Rusted JM. 1988. Dissociative effects of scopolamine on working memory in healthy young volunteers. Psychopharmacology 96: 487-492.
56. Rusted J, Eaton-Williams P. 1991. Distinguishing between attentional and amnestic effects in information processing: the separate and combined effects of scopolamine and nicotine on verbal free recall. Psychopharmacology 104: 363-366.
57. Rusted JM, Eaton-Williams P, Warburton DM. 1991. A comparison of the effects of scopolamine and diazepam on working memory. Psychopharmacology 105: 442-445.
58. Rusted JM, Warburton DM. 1988. The effects of scopolamine on working memory in healthy young volunteers. Psychopharmacology 96: 145-152.
59. Silver MA, Shenhav A, D'Esposito M. 2008. Cholinergic enhancement reduces spatial spread of visual responses in human early visual cortex. Neuron 60: 904-914.
60. Shigeta M, Homma A. 2001. Donepezil for Alzheimer's disease: pharmacodynamic, pharmacokinetic, and clinical profiles. CNS Drug Rev 7: 353-368.
61. Squire LR. 1986. Mechanisms of memory. Science 232: 1612-1619.
62. Stough C, Mangan G, Bates T, Frank N, Kerkin B, Pellett O. 1995. Effects of nicotine on perceptual speed. Psychopharmacology 119: 305-310.
63. Sun X, Zhang X, Chen X, et al. 2005. Age-dependent brain activation during forward and backward digit recall revealed by fMRI. Neuroimage 26: 36-47.
64. Thiel CM, Zilles K, Fink GR. 2005. Nicotine modulates reorienting of visuospatial attention and neural activity in human parietal cortex. Neuropsychopharmacology 30: 810-820.
65. Thompson JC, Stough C, Ames D, Ritchie C, Nathan PJ. 2000. Effects of the nicotinic antagonist mecamilamine on inspection time. Psychopharmachology 150: 117-119.
66. Thompson JC, Whilby G, Stough C. 2002. The effects of transdermal nicotine on inspection time. Hum Psychopharmacol 17: 157-161.
67. Thomas E, Snyder PJ, Pietrzak RH, Jackson CE, Bednar M, Maruff P. 2008. Specific impairments in visuospatial working and short-term memory following low-dose scopolamine challenge in healthy older adults. Neuropsychologia 46: 2476-2484.
68. Warburton DM, Rusted JM. 1993. Cholinergic control of cognitive resources. Neuropsychobiology 28: 43-46.
69. Wezenberg E, Verkes RJ, Sabbe BGC, Ruigt GSF, Hulstijin W. 2005. Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly health subjects. Psychopharmacology 181: 582-594.
70. Wechsler DA. 1955. Manual for the Wechsler Adult Intelligence Scale. National Foundation for Educational Research: London.